You are not logged in.
Login to update your contact information or edit your email preferences, or Register to create an account.
Rep. Jason Chaffetz (R-UT) has composed a letter to FDA expressing disappointment over FDA’s dismissal of Senators Hatch and Harkin’s request and
reiterating that Congress did not intend to give FDA pre-market review of new
dietary ingredients, nor did it intend to permit the agency to treat dietary
ingredients in the same manner as food additives.
The letter goes on to articulate the legal problems with
FDA’s proposal, and strongly urges FDA to withdraw its guidance and instead
design a fair and workable NDI notification system. It also requests that FDA
refrain from taking any enforcement action that is based solely on positions
articulated in the draft guidance that are not unequivocally grounded in the
Please ask your congressional representative to sign onto
Rep. Chaffetz’s letter to FDA. Reiterate the serious concerns with NDI
guidance—how it severely threatens access to thousands of supplements, even
though supplements have a proven safety record (unlike FDA-approved drugs!).
(Please personalize your message if you have the time!)
Dear [Decision Maker],
Sincerely,[Your Name] [Your Address] [City, State ZIP]